A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine With or Without IL-12 DNA Adjuvant, Boosted With Homologous Plasmids in Healthy, HIV-1 Uninfected Adult Participants.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs HIV DNA vaccine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 10 Sep 2012 Biomarkers information updated
- 01 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 May 2007 Status changed from recruiting to in progress.